INOVIO PHARMACEUTICALS INC
INO · NASDAQ
Updated at 2026-10-14 09:17:16
- Today's High
- $1.11
- Today’s Low
- $0.95
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.16
- Previous Close
- $1.10
- Volume
- 2.33M
- Market Cap
- $114.25M
- P/E Ratio
- --
- EPS
- $-1.16
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 660 WEST GERMANTOWN PIKE, PLYMOUTH MEETING, PA, UNITED STATES, 19462
- Country
- US
- Listing Date
- 1998-12-08
- Fiscal Year End
- December
- Shares Outstanding
- 82.27M
- CIK
- 0001055726
- Website
- www.inovio.com
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA drugs to treat and protect people from diseases associated with the human papillomavirus (HPV), cancer, and infectious diseases.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
-$65.34K
2025-09-30
$0
Operating Expenses
2026-06-30
$18.62M
2026-03-31
$21.2M
2025-12-31
$16.72M
2025-09-30
$21.21M
Net Income
2026-06-30
-$6.01M
2026-03-31
-$19.68M
2025-12-31
$3.76M
2025-09-30
-$45.49M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
-5.76K%
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.07
2026-03-31
$-0.31
2025-12-31
$-0.27
2025-09-30
$-0.87
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$5.24M
2026-03-31
-$18.93M
2025-12-31
$4.51M
2025-09-30
-$44.74M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | -$65.34K | $0 |
| Operating Expenses | $18.62M | $21.2M | $16.72M | $21.21M |
| Net Income | -$6.01M | -$19.68M | $3.76M | -$45.49M |
| Net Profit Margin | -- | -- | -5.76K% | -- |
| Earnings Per Share | $-0.07 | $-0.31 | $-0.27 | $-0.87 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$5.24M | -$18.93M | $4.51M | -$44.74M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.